These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6101953)

  • 1. The effect of inflammatory disease on plasma concentrations of three beta-adrenoceptor blocking agents [proceedings].
    Bishop H; Kendall MJ; Quarterman CP; Schneider RE
    Br J Clin Pharmacol; 1980 Jan; 9(1):108P-109P. PubMed ID: 6101953
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of inflammatory disease on plasma concentrations of three beta-adrenoceptor blocking agents.
    Schneider RE; Bishop H; Kendall MJ; Quarterman CP
    Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):158-62. PubMed ID: 6114930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a radioreceptor assay for beta-adrenoceptor antagonists in plasma [proceedings].
    Barnett DB; Batta MI; Nahorski SR
    Br J Pharmacol; 1978 Nov; 64(3):449P. PubMed ID: 31225
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating beta-adrenoceptor blocking factors in asthma.
    Basran GS; Ball AJ; Hanson JM; Morley J; Turner-Warwick M
    Eur J Respir Dis Suppl; 1984; 135():226-8. PubMed ID: 6145614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood concentrations and pharmacodynamic effects of SL 75212, a new beta-adrenoceptor antagonist, after oral and intravenous administration [proceedings].
    Bianchetti G; Gomeni R; Kilborn JR; Morselli PL; Taylor EA; Warrington SJ
    Br J Clin Pharmacol; 1979 Oct; 8(4):403P-404P. PubMed ID: 41556
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta-adrenoceptor blocking drugs at maximum beta-blockade in relation to dose and plasma concentration.
    Gugler R; Krist R; Raczinski H; Höffgen K; Boden G
    Cardiology; 1979; 64 Suppl 1():20-4. PubMed ID: 42486
    [No Abstract]   [Full Text] [Related]  

  • 8. Duration of action and plasma levels of beta-adrenoceptor blocking drugs.
    Aellig WH
    Arch Int Pharmacodyn Ther; 1980; Suppl():32-7. PubMed ID: 6106456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pravastatin reverses the down-regulating effect of inflammation on beta-adrenergic receptors: a disease-drug interaction between inflammation, pravastatin, and propranolol.
    Clements JD; Jamali F
    Vascul Pharmacol; 2007 Jan; 46(1):52-9. PubMed ID: 16949884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of beta-adrenoceptor antagonists on proinflammatory cytokine concentrations after subarachnoid hemorrhage in rats.
    Kato H; Kawaguchi M; Inoue S; Hirai K; Furuya H
    Anesth Analg; 2009 Jan; 108(1):288-95. PubMed ID: 19095864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacodynamics and plasma levels of beta-adrenoceptor blocking drugs.
    Gugler R; Krist R; Raczinski H; Höffgen K; Bodem G
    Br J Clin Pharmacol; 1980 Oct; 10(4):337-43. PubMed ID: 6108780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a relationship between the physical properties and cardioselectivity of beta-adrenoceptor antagonists?
    Jack DB
    Br J Clin Pharmacol; 1981 Apr; 11(4):402-6. PubMed ID: 6114740
    [No Abstract]   [Full Text] [Related]  

  • 13. An assessment of beta-adrenoceptor blockade in man by SK & F 92657, a new drug with combined vasodilator and beta-adrenoceptor blocking actions, and comparison with propranolol [proceedings].
    Pitcher DW; Curry PV; Trounce JR
    Br J Clin Pharmacol; 1980 Mar; 9(3):300P-301P. PubMed ID: 6102474
    [No Abstract]   [Full Text] [Related]  

  • 14. The assessment of beta-adrenoceptor blocking drugs in man.
    McDevitt DG
    Br J Clin Pharmacol; 1977 Aug; 4(4):413-25. PubMed ID: 20123
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between plasma beta-adrenoceptor blocker concentration and pharmacodynamic activity.
    Silke B
    Br J Clin Pharmacol; 1982 Feb; 13(2):256-7. PubMed ID: 6120714
    [No Abstract]   [Full Text] [Related]  

  • 16. A further study on antihypertensive action of beta-adrenoceptor blocking agents in conscious, renal hypertensive dogs.
    Himori N; Ishimori T; Taira N
    Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):115-27. PubMed ID: 44454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow release beta-adrenoceptor blocking drugs.
    Harron DW; Howe A; Shanks RG
    J R Coll Physicians Lond; 1983 Apr; 17(2):126-32. PubMed ID: 6132994
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta-adrenoceptor changes in blood lymphocytes and altered drug responsiveness.
    Brodde OE; Wang XL
    Ann Clin Res; 1988; 20(5):311-23. PubMed ID: 2905876
    [No Abstract]   [Full Text] [Related]  

  • 19. [Beta-blocking agents].
    Suzuki M
    Nihon Rinsho; 1995 Feb; 53 Su Pt 1():978-82. PubMed ID: 8753603
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of beta-adrenoceptor blocking agents: clinical significance of hepatic and/or renal clearance.
    Borchard U
    Clin Physiol Biochem; 1990; 8 Suppl 2():28-34. PubMed ID: 1982759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.